:.START

Amgen Inc. dey yarn di second quarter earnings increase dan to ten times ten to $3.9 million, or 22 cents a share due to increase sales of di company new antianemia medicine for kidney patients.

Thousand Oaks, Calif.-based biotechnology company talk sey dia revenue na 97% increase from di quarter to $42.5 million for di quarter wey end September 30.

For di year ago period, Amgen go report di net of $320,000, or two cents a share, on top of $21.5 million.

For di six months, di company talk sey na more dan six times wey dem dey report sey di company don increase dia earnings to $4.7 million, or 26 cents a share, from $625,000, or four cents wey dey di same year.

Budget increase from 77% to $72.6 million from last year to $41 million.

